Doctor Agata Tyminska
Medical University of Warsaw, Warsaw (Poland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Association of galectin-3 and soluble ST2, and their changes, with echocardiographic parameters and development of heart failure after ST-segment elevation myocardial infarction.
Event: EuroEcho 2019
Topic: Systolic and Diastolic Function
Session: Echocardiography: Systolic and Diastolic Function
Carcinoid heart disease
Event: EuroEcho 2019
Topic: Valvular Heart Disease
Session: Echocardiography: Valve Disease
Influence of galectin-3 and soluble ST-2 on risk of death and heart failure hospitalization in patients after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Event: Heart Failure 2019
Topic: Biomarkers
Session: Chronic Heart Failure – Diagnostic Methods
Ischemic versus dilated cardiomyopathy - differences in clinical characteristics and prognosis depending on heart failure etiology.
Event: ESC Congress 2017
Topic: Prognosis
Session: Comorbidities in heart failure
Heart failure with Mid-Range ejection fraction - clinical characteristics and in-hospital outcomes. Insights into novel enigma based on the results from the ESC-HF Registries.
Event: ESC Congress 2017
Topic: Heart failure, other
Session: Acute heart failure (AHF)
Differences between randomized controlled clinical trials and real-world atrial fibrillation patients treated with oral anticoagulants - do we treat the same patients? Results from the CRAFT study
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke prevention
ESC 365 is supported by
